• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用气相色谱-质谱碎片分析法同时测定血浆和全血中多塞平及其主要代谢物。

Simultaneous measurement of dothiepin and its major metabolites in plasma and whole blood by gas chromatography-mass fragmentography.

作者信息

Maguire K P, Norman T R, Burrows G D, Scoggins B A

出版信息

J Chromatogr. 1981 Mar 13;222(3):399-408. doi: 10.1016/s0378-4347(00)84140-7.

DOI:10.1016/s0378-4347(00)84140-7
PMID:7228947
Abstract

A method for the simultaneous measurement of dothiepin and two of its major metabolites, northiaden and dothiepin S-oxide in both plasma and whole blood is described. The method involves the use of gas chromatography-mass fragmentography. It is selective, sensitive (1 microgram/1) and reproducible. It has been used to analyse both plasma and blood samples following single oral doses of 75 mg dothiepin in seven volunteers.

摘要

本文描述了一种同时测定血浆和全血中多塞平及其两种主要代谢物去甲替林和多塞平S-氧化物的方法。该方法采用气相色谱-质谱碎片分析法。它具有选择性、灵敏性(1微克/升)和可重复性。已用于分析7名志愿者单次口服75毫克多塞平后的血浆和血样。

相似文献

1
Simultaneous measurement of dothiepin and its major metabolites in plasma and whole blood by gas chromatography-mass fragmentography.采用气相色谱-质谱碎片分析法同时测定血浆和全血中多塞平及其主要代谢物。
J Chromatogr. 1981 Mar 13;222(3):399-408. doi: 10.1016/s0378-4347(00)84140-7.
2
Blood and plasma concentrations of dothiepin and its major metabolites and clinical response.多塞平及其主要代谢物的血液和血浆浓度与临床反应。
J Affect Disord. 1982 Mar;4(1):41-8. doi: 10.1016/0165-0327(82)90018-0.
3
Chemical ionisation mass fragmentographic measurement of dothiepin plasma concentrations following a single oral dose in man.单次口服剂量后人体血浆中多塞平浓度的化学电离质谱碎片分析法测定
J Chromatogr. 1980 Aug 8;183(2):141-48. doi: 10.1016/s0378-4347(00)81687-4.
4
High performance liquid chromatographic determination of dothiepin and northiaden in human plasma and serum.高效液相色谱法测定人血浆和血清中的多塞平及去甲替林
J Int Med Res. 1977;5(6):387-90. doi: 10.1177/030006057300100201.
5
Metabolism and pharmacokinetics of dothiepin.多虑平的代谢与药代动力学
Br J Clin Pharmacol. 1981 Sep;12(3):405-9. doi: 10.1111/j.1365-2125.1981.tb01235.x.
6
Clinical pharmacokinetics of dothiepin. Single-dose kinetics in patients and prediction of steady-state concentrations.
Clin Pharmacokinet. 1983 Mar-Apr;8(2):179-85. doi: 10.2165/00003088-198308020-00004.
7
Measurement of dothiepin and its major metabolites in plasma by high-performance liquid chromatography.采用高效液相色谱法测定血浆中多塞平及其主要代谢物。
J Chromatogr. 1992 Oct 2;581(1):152-5. doi: 10.1016/0378-4347(92)80460-8.
8
Urinary excretion of conjugates of dothiepin and northiaden (mono-N-demethyl-dothiepin) after an oral dose of dothiepin to humans.给人类口服多塞平后,其与去甲替林(单-N-去甲基多塞平)结合物的尿排泄情况。
Eur J Drug Metab Pharmacokinet. 1986 Jan-Mar;11(1):29-32. doi: 10.1007/BF03189772.
9
Assessment of the antidepressant activity of dothiepin and its metabolites by preclinical tests.
J Affect Disord. 1982 Sep;4(3):261-9. doi: 10.1016/0165-0327(82)90010-6.
10
Severe dothiepin intoxication--a report of two cases.严重多虑平中毒——两例报告
Postgrad Med J. 1984 Jun;60(704):442-4. doi: 10.1136/pgmj.60.704.442.

引用本文的文献

1
Metabolism and pharmacokinetics of dothiepin.多虑平的代谢与药代动力学
Br J Clin Pharmacol. 1981 Sep;12(3):405-9. doi: 10.1111/j.1365-2125.1981.tb01235.x.
2
A pharmacokinetic study of mianserin.米安色林的药代动力学研究。
Eur J Clin Pharmacol. 1982;21(6):517-20. doi: 10.1007/BF00542048.
3
Clinical pharmacokinetics of dothiepin. Single-dose kinetics in patients and prediction of steady-state concentrations.
Clin Pharmacokinet. 1983 Mar-Apr;8(2):179-85. doi: 10.2165/00003088-198308020-00004.
4
Age differences in effects on blood pressure, flicker fusion frequency, salivation and pharmacokinetics of single oral doses of dothiepin and amitriptyline.单次口服多塞平与阿米替林对血压、闪烁融合频率、唾液分泌及药代动力学影响的年龄差异。
Eur J Clin Pharmacol. 1983;25(6):811-4. doi: 10.1007/BF00542525.